NEW YORK, Sept.18 - Genomic drug target discovery company Oxagen of Milton Park, UK is seeking to raise as much 30 million pounds ($42 million) in private financing and is considering an initial public offering for 2001, Reuters reported Monday.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.